Is Global Health technically bullish or bearish?
2025-12-02 09:26:10Overview of Technical Trend Shift As of 1 December 2025, Global Health’s technical trend has transitioned from mildly bullish to sideways. This change indicates that the stock is no longer exhibiting clear upward momentum but is instead moving within a range, neither strongly advancing nor declining. Such sideways trends often signal market indecision or a pause before the next significant move. The hospital industry, to which Global Health belongs, has been under scrutiny due to evolving healthcare demands and regulatory environments. Investors often rely on technical analysis to gauge short- to medium-term price movements, especially when fundamental catalysts are less pronounced. Key Technical Indicators: Mixed Signals Examining the Mo...
Read More
Global Health Stock Analysis: Technical Momentum Shifts Amid Mixed Signals
2025-12-02 08:12:46Global Health, a key player in the hospital sector, is currently exhibiting a nuanced shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition from a mildly bullish trend to a sideways movement, underscoring a period of consolidation for the stock amid mixed technical indicator signals.
Read MoreHow has been the historical performance of Global Health?
2025-12-01 23:40:16Revenue and Profit Growth Trajectory Global Health’s net sales have shown a robust upward trend, rising from ₹1,446.74 crores in the fiscal year ending March 2021 to ₹3,692.32 crores by March 2025. This represents a compound annual growth rate (CAGR) of approximately 26.5%, signalling strong market demand and effective business expansion. Operating profit before depreciation and interest (PBDIT) excluding other income also increased significantly, from ₹191.43 crores in 2021 to ₹877.07 crores in 2025, highlighting improved operational leverage. The company’s consolidated net profit followed a similar trajectory, surging from ₹28.81 crores in 2021 to ₹481.44 crores in 2025. Despite a slight dip in profit margins in the latest year, the profit after tax margin remains he...
Read More
Global Health’s Evaluation Revised Amid Mixed Financial and Market Signals
2025-11-26 09:46:20Global Health, a midcap player in the hospital sector, has experienced a revision in its market evaluation reflecting a nuanced view of its recent financial and technical performance. This shift follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, providing investors with a clearer understanding of its current standing.
Read MoreWhy is Global Health falling/rising?
2025-11-25 01:45:16Recent Price Performance and Market Context Global Health’s share price has demonstrated resilience over multiple time horizons. While the stock has declined by 6.98% over the past month, it has outperformed the Sensex benchmark significantly over the year-to-date period with a 15.70% gain compared to the Sensex’s 8.65%. Over the last year, the stock has appreciated by 12.14%, nearly doubling the benchmark’s 7.31% return. The most striking performance is seen over three years, where Global Health surged by 172.53%, vastly outpacing the Sensex’s 36.34% gain. This long-term outperformance underscores the company’s sustained growth trajectory and investor confidence in its fundamentals. On the day in question, the stock outperformed its sector by 3.1%, reaching an intrada...
Read MoreIs Global Health technically bullish or bearish?
2025-11-20 08:12:58As of 19 November 2025, the technical trend has changed from sideways to mildly bullish. The current technical stance is mildly bullish, driven primarily by the daily moving averages indicating bullish momentum. However, the weekly MACD and Bollinger Bands are both mildly bearish, suggesting some caution. The KST is bullish on the weekly timeframe, while the Dow Theory shows no trend on the weekly and mildly bearish on the monthly. Overall, the mixed signals indicate a cautious bullish outlook....
Read More
Global Health Stock Analysis: Technical Momentum Shift and Market Returns
2025-11-20 08:09:07Global Health, a key player in the hospital sector, has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This development, coupled with mixed signals from key technical indicators such as MACD, RSI, and moving averages, provides a nuanced perspective on the stock’s current market behaviour and performance relative to benchmarks like the Sensex.
Read MoreIs Global Health overvalued or undervalued?
2025-11-20 08:07:53As of 19 November 2025, the valuation grade for Global Health has moved from expensive to very expensive, indicating a significant shift in its perceived market value. The company is currently deemed overvalued. Key ratios highlight this assessment, with a PE ratio of 53.76, a Price to Book Value of 8.70, and an EV to EBITDA of 33.44, all of which are considerably high compared to industry norms. In comparison to its peers, Global Health's valuation stands out, particularly when looking at Max Healthcare with a PE of 80.06 and Apollo Hospitals at 64.09. This suggests that while Global Health is indeed very expensive, it is relatively more attractive than some of its peers. Notably, the company has shown a strong return of 189.89% over the past three years, outperforming the Sensex's 38.15% return during the same period, which may contribute to its elevated valuation despite the current market conditions....
Read MoreIs Global Health technically bullish or bearish?
2025-11-19 08:16:59As of 18 November 2025, the technical trend for Global Health has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed indicators influencing this outlook. The weekly MACD and Bollinger Bands are both mildly bearish, while the daily moving averages show a mildly bullish signal. The KST indicates a bullish stance on the weekly timeframe, but the Dow Theory shows no trend on the weekly and mildly bearish on the monthly. Overall, the strength of the current neutral stance is weak, with no strong bullish or bearish signals dominating the analysis....
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
30-Jan-2026 | Source : BSEIntimation for Earning Conference Call under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015.
Board Meeting Intimation for Board Meeting Intimation For Schedule Of Board Meeting For Third Quarter And Nine-Months Ended December 31 2025 Under Regulation 29 Of Listing Regulations.
24-Jan-2026 | Source : BSEGlobal Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 inter alia to consider and approve Unaudited Financial Results for Third quarter and Nine-Months ended December 31 2025.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Jan-2026 | Source : BSECertificate under Regulation 74(5) of SEBI (DP) Regulations 2018 is enclosed.
Corporate Actions
No Upcoming Board Meetings
Global Health Ltd has declared 25% dividend, ex-date: 22 Aug 25
No Splits history available
No Bonus history available
No Rights history available